JPMorgan Downgrades Genpact Ltd. (G) to Underweight Citing NT Challenges
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts G Hot Sheet
Price: $40.78 +1.39%
Rating Summary:
11 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
11 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
JPMorgan analyst Tien-tsin Huang downgraded Genpact Ltd. (NYSE: G) from Neutral to Underweight with a price target of $33.00.
For an analyst ratings summary and ratings history on Genpact Ltd. click here. For more ratings news on Genpact Ltd. click here.
Shares of Genpact Ltd. closed at $30.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Double Downgrades Aardvark Therapeutics Inc (AARD) to Market Perform
- Oppenheimer Downgrades Fidelity National Information Services (FIS) to Perform
- Barclays Downgrades Skyworks Solutions (SWKS) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
